Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityNo recent work listed

Zhi‐Qiang Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6232-1684; OpenAlex author ID A5100755442. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper

Papers 2

  1. The efficacy and safety of modified FOLFIRINOX as first-line chemotherapy for Chinese patients with metastatic pancreatic cancer. Co-author DOI 10.1186/s40880-019-0367-7↗
  2. ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Co-author DOI 10.1002/ijc.26376↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. De‐Shen Wang · 2 shared papers, 2012–2019 · strength 0.12
  2. Feng‐Hua Wang · 2 shared papers, 2012–2019 · strength 0.12
  3. Rui‐Hua Xu · 2 shared papers, 2012–2019 · strength 0.12
  4. Yuhong Li · 2 shared papers, 2012–2019 · strength 0.12
  5. Ting Deng · 1 shared paper, 2019 · strength 0.09
  6. Fei Zhang · 1 shared paper, 2019 · strength 0.09
  7. Le Zhang · 1 shared paper, 2019 · strength 0.09
  8. Wei Wang · 1 shared paper, 2019 · strength 0.09
  9. Yi Ba · 1 shared paper, 2019 · strength 0.09
  10. Dongsheng Zhang · 1 shared paper, 2012 · strength 0.03
  11. Miao‐Zhen Qiu · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.